Ariel3: Phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) Meeting Abstract
| Authors: | Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A.; Scambia, G.; Leary, A.; Holloway, R. W.; O'Malley, D. M.; Cameron, T.; Maloney, L.; Goble, S.; Lin, K. K.; Sun, J.; Giordano, H.; Coleman, R. L. |
| Abstract Title: | Ariel3: Phase 3, randomised, double-blind study of rucaparib vs placebo following response to platinum-based chemotherapy for recurrent ovarian carcinoma (OC) |
| Meeting Title: | 20th International Meeting of the European Society of Gynaecological Oncology (ESGO) |
| Journal Title: | International Journal of Gynecological Cancer |
| Volume: | 27 |
| Issue: | Suppl. 4 |
| Meeting Dates: | 2017 Nov 4-7 |
| Meeting Location: | Vienna, Austria |
| ISSN: | 1048-891X |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2017-11-01 |
| Start Page: | 10 |
| End Page: | 11 |
| Language: | English |
| ACCESSION: | WOS:000423235201009 |
| PROVIDER: | wos |
| DOI: | 10.1097/01.IGC.0000527296.86225.87 |
| Notes: | Meeting Abstract: ESGO7-1518 -- Also appears on pages 1972-1973 of the issue -- Source: Wos |
